Enliven Therapeutics Inc (ELVN)’s stock has witnessed a price hike of 1.15% from the previous close with its current price standing at $18.71. Its current price is -37.69% under its 52-week high of $30.03 and 40.69% more than its 52-week low of $13.30.
How does Enliven Therapeutics Inc (ELVN) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Enliven Therapeutics Inc (ELVN): Earnings History
If we examine Enliven Therapeutics Inc’s recent earnings history, in the last quarter ended on 6/30/2025, it posted adjusted earnings per share of -$0.49, beating the consensus of -$0.42. In other words, it beat the consensus by -$0.07, resulting in a -16.67% surprise. In the 3 months period before the previous quarter which was closed on 6/30/2025, the stock recorded adjusted earnings per share of -$0.49 in contrast with the Outlook of -$0.42. That was a difference of -$0.07 and a surprise of -16.67%.
Enliven Therapeutics Inc (NASDAQ: ELVN) Ownership Details
I will give a breakdown of the key shareholders in Enliven Therapeutics Inc (ELVN). Recent figures show that the company’s insiders hold 8.88% of shares. A total of 185 institutional investors hold shares in the company, making 102.24% of its stock and 112.21% of its float.
Jun 30, 2025, it was reported that the Company’s largest institutional holder is VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holding total of 1.38 shares that make 2.34% of the company’s total number of shares and are currently priced at 25.6 million.
The securities firm Fidelity Select Portfolios-Select Health Care Portfolio holds 1.22 shares of ELVN, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 2.06%, and the holding percentage of shares is valued at 22.55 million.
